2min chapter

Investing With IBD cover image

Ep 182: Simon Erickson: EV Stocks Powering Up?

Investing With IBD

CHAPTER

CME: Arusha's Growth Strategy

It's right up there on kind of the when you look at the screening from an O'Neill perspective EPS rating of 92. So outperforming 92% of the stocks in our database and RS rating of 93. It is setting up it broke out of a consolidation. You can see now the focus on where the money is at, right? Gross margin just within the past year alone grew from 32% to 38%.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode